Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
US Congress lets Medicare negotiate lower drug pricesJaffe, SusanThe Lancet (British edition), 2022-08, Vol.400 (10352), p.551-552 [Periódico revisado por pares]London: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Measuring US Pharmaceutical Industry R&D SpendingGolec, Joseph ; Vernon, JohnPharmacoEconomics, 2008-01, Vol.26 (12), p.1005-1017 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
US pharmaceutical companies sue to halt cuts in drug pricesJaffe, SusanThe Lancet (British edition), 2023-07, Vol.402 (10399), p.359-360 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Misleading Congress About Drug DevelopmentLight, Donald W.Journal of Health Politics, Policy and Law, 2007-10, Vol.32 (5), p.895-913 [Periódico revisado por pares]Duke University PressTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
When Will the FDA Do What Is in People’s Best Interests?Ordman, Alfred B.The American journal of economics and sociology, 2022-09, Vol.81 (4), p.721-751 [Periódico revisado por pares]New York: Blackwell Publishing LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Misleading Congress About Drug Development: ReplyDiMasi, Joseph A. ; Hansen, Ronald W. ; Grabowski, Henry G.Journal of health politics, policy and law, 2008-04, Vol.33 (2), p.319-324 [Periódico revisado por pares]United States: Duke University PressTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
US President's science panel advises on antibiotic resistanceJaffe, SusanThe Lancet (British edition), 2014-09, Vol.384 (9948), p.1083-1084 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and AssessmentSchlander, Michael ; Hernandez-Villafuerte, Karla ; Cheng, Chih-Yuan ; Mestre-Ferrandiz, Jorge ; Baumann, MichaelPharmacoEconomics, 2021-11, Vol.39 (11), p.1243-1269 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
The Pharmaceutical Access Act: An Administrative Eminent Domain Solution to High Drug PricesBruns, Brittany S.California law review, 2018-12, Vol.106 (6), p.2023-2066 [Periódico revisado por pares]Berkeley CA United States of America: California Law Review, IncTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from IndiaDuggan, Mark ; Garthwaite, Craig ; Goyal, AparajitaThe American economic review, 2016-01, Vol.106 (1), p.99-135 [Periódico revisado por pares]Nashville: American Economic AssociationTexto completo disponível |